A Series C financing round co-led by Valiance and RMM has brought in $26.5 million for Irvine, Calif.-based JenaValve Technology. The firm will use the money to advance its replacement heart valve and support its growth in the worldwide transcatheter aortic valve implants market.
A joint funding round has brought in $26.5 million for sister firms 480 Biomedical and Arsenal Medical. Arsenal plans to use its $16 million funding for the creation of a nanofiber drug delivery technology and an acute abdominal hemorrhaging treatment. The $10.5 million that 480 Biomedical raised will be used for designing a bioresorbable scaffold for patients with occlusive disease in the superficial femoral artery.
Biocept hopes to raise $26.5 million in gross proceeds from its planned initial public offering, up from its original target of $24.3 million. The San Diego company specializes in circulating tumor cell-based cancer tests as well as circulating tumor DNA diagnostics, which employ standard blood specimens.
Minneapolis is weighing a possible sale of retail center Gaviidae I to a New York company that is offering $26.5 million. The city owns a 34% stake in the center, with the remaining stake owned by Brookfield Properties. The city will review the offer July 9.
Cedar Shopping Centers has acquired Cross Keys Place in Sewell, N.J., for $26.5 million. It purchased the retail center on behalf of its joint venture with RioCan Real Estate Investment Trust. Cross Keys Place is anchored by Sports Authority, Bed, Bath & Beyond, AC Moore, Old Navy and Petco.